Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Open-label, Parallel Group Study of Abiraterone Acetate Plus Prednisone in African American and Caucasian Men With Metastatic Castrate-resistant Prostate Cancer

NCT01940276 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT01940276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01940276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Open-label, Parallel Group Study of Abiraterone Acetate Plus Prednisone in African American and Caucasian Men With Metastatic Castrate-resistant Prostate Cancer
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2013
Completion date
October 8, 2019
Enrollment
100 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer